The PennZone

MEDFIELD, Mass. - PennZone -- Acmeware, a MEDITECH Alliance Partner, announced a partnership with Avo (AvoMD), an AI platform for clinical copilots and a fellow MEDITECH Alliance Partner. Together, the organizations are enabling MEDITECH customers to seamlessly push and pull data between MEDITECH and Avo's AI-powered clinical tools. As part of this partnership, Acmeware will serve as a seamless data integration layer for Avo's AI suite within MEDITECH environments, delivering a standards-based API using the HL7® FHIR® data format.

Through Acmeware's FHIR-enabled API, Avo can securely access real-time clinical data from MEDITECH to power context-aware, evidence-based decision support at the point of care. The integration is designed to align with MEDITECH architecture and interoperability frameworks while minimizing implementation complexity for provider organizations with one simple install.

Early adopters of the Acmeware–Avo integration include Moab Regional Hospital, Emanate Health, and Holyoke Medical Center, all of which are leveraging the solution to streamline access to AI-generated insights and documentation directly within their MEDITECH systems.

AI capabilities that will be further enhanced with this real-time integration include: Avo's Chart Assist functionality for workflows like pre-charting, admissions, and discharge, Ask Avo, a smart EHR-search and AI consult with patient data awareness, and AI Scribe, with longitudinal patient context awareness and automatic note-pushing.

More on The PennZone

• International Law Group Expands Emergency Immigration Consultations for Somali Minnesotans Amid ICE Actions
• Premium Bail Bonds Proudly Sponsors BOFAB BBQ Team at the 2026 Lakeland Pigfest
• UK Financial Ltd Receives Recognition In Platinum Crypto Academy's "Cryptonaire Weekly"
• Nell Tice Empowers Small Businesses Through Strategic Video Production
• P-Wave Press Announces Pushing the Wave 2024 by L.A. Davenport

"This partnership reflects our focus on delivering production-grade interoperability using modern standards," said Joel Benware, President and CEO of Acmeware. "By exposing MEDITECH data through a robust FHIR-based API, we're giving healthcare organizations flexible, scalable options to connect Avo's AI-driven insights directly to MEDITECH."

The collaboration expands upon Avo's existing relationship with MEDITECH through its Alliance partnership, while offering customers additional integration paths powered by Acmeware's interoperability expertise. Acmeware's integration layer ensures reliable access to the required clinical context—including patient, encounter, and observation data—while maintaining performance, security, and compliance requirements.

"At Avo, we've partnered with over 30 MEDITECH customers to support clinical workflows with the latest and greatest in AI at the point of care," said Joongheum Park, MD, Chief Product & AI Officer at Avo. "Working with Acmeware allows us to extend the value of our AI tools within MEDITECH environments in ways that fit naturally into provider workflows."

The partnership supports healthcare organizations seeking to extend MEDITECH with external clinical decision support capabilities while adhering to interoperability best practices. Together, Acmeware and Avo aim to simplify integration, reduce maintenance overhead, and support clinically meaningful use of real-time data.

Why it matters

As healthcare organizations increasingly look to extend EHR functionality using third-party applications, standards-based integration has become critical. This partnership highlights how FHIR APIs can be used to deliver real-time clinical decision support in MEDITECH environments.

More on The PennZone

• Preston Dermatology & Skin Surgery Center Wins Gold and Bronze in Prestigious Annual DIAMOND Awards
• David Boland, Inc. Awarded $54.3M Construction Contract by U.S. Army Corps of Engineers, Savannah District
• Pawprint Oxygen Turns Pet Safety Viral With "Pets Live Here" Window Decals — Helping First Responders Save Lives
• "Phinge Unveil™" Coming to Las Vegas to Showcase Netverse Patented Verified App-less Platform, AI & Modular Hardware Including Developer Conferences
• Elizabeth McLaughlin, Founder and CEO of Red Wagon Group, named 2026 Presidential Leadership Scholar

For more information about Acmeware, visit www.acmeware.com.

For more information about AvoMD, visit www.avomd.com.

2 / 2

About Acmeware

Acmeware, Inc. provides data integration, professional services, training, solutions, and custom software that assist clients in realizing the maximum benefit from their MEDITECH EHR. We are a service-oriented company working in partnership with our clients to leverage the latest technologies, transform disparate raw data to knowledge, and deliver valuable insight to healthcare organizations. Acmeware's dedicated focus on MEDITECH related services allows us to provide solutions that are innovative, efficient, accurate, and affordable. acmeware.com

About Avo

Avo is the future-proof AI platform used by healthcare organizations to improve care and operational outcomes in a way clinicians love. Avo's platform offers end-to-end EHR copilots that simplify everyday clinical tasks like documentation, charting, discharge planning, ordering and more. Avo supports every member of the care team by effortlessly incorporating guidelines, protocols, and patient data into the workflow and transforming them into actionable tools. At Avo, we believe in standardizing care with love, not alerts. Visit avomd.com to learn more.